ArticleAmyotrophic lateral sclerosis & frontotemporal degeneration2020
Reliability and validity of speech & pause measures during passage reading in ALS.
Registry-linked trialOpen access · greenAbstract read
In one paragraph
Article in Amyotrophic lateral sclerosis & frontotemporal degeneration, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05137665 (Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At - Home Measures), which is not on this map. Cited by 36 papers.
0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At - Home Measures
Who cites it
36 citing papers in PubMed, 55 citations in OpenAlex.
- Improving Perceptual Speech Ratings: The Effects of Auditory Training on Judgments of Dysarthric Speech.Journal of speech, language, and hearing research : JSLHR · 2023Trial
- Dissociable Effects of Dysarthria Etiology and Severity on the Minimally Detectable Change of Speech Intelligibility.Journal of speech, language, and hearing research : JSLHR · 2026Article
- Digital Remote Assessment of Motor and Speech Changes in Amyotrophic Lateral Sclerosis: Longitudinal Observational Study.JMIR formative research · 2026Observational
- Speech-based digital endpoints track ALS progression and align with standard clinical outcomes: evidence from the VRG50635 trial.Scientific reports · 2026Article
- Clinical evaluation of communication brain computer interfaces in amyotrophic lateral sclerosis: a landscape analysis.Frontiers in human neuroscience · 2026Article
- Differentiating upper- and lower motor neuron diseases using automated acoustic analysis.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2025Article
- Exploring Methodological Decisions for Calculating the Minimally Detectable Change in Dysarthria: Reliability, Statistics, and Standard Error of Measurement.Journal of speech, language, and hearing research : JSLHR · 2025Article
- A Preliminary Investigation of Acoustic Features for Remote Monitoring of Respiration in ALS.Muscle & nerve · 2025Article
- Progress Toward Estimating the Minimal Clinically Important Difference of Intelligibility: A Crowdsourced Perceptual Experiment.Journal of speech, language, and hearing research : JSLHR · 2025Article
- Collection and Analysis of Repeated Speech Samples: Methodological Framework and Example Protocol.JMIR research protocols · 2025Article
- Construct Validity of the Amyotrophic Lateral Sclerosis Bulbar Dysfunction Index-Remote.American journal of speech-language pathology · 2025Article
- Minimal Detectable Change of Experienced and Novice Listeners' Ratings of Overall Severity of Voice Quality in Adductor Laryngeal Dystonia.Journal of speech, language, and hearing research : JSLHR · 2025Article
- A digital measure of eye movements during reading sensitively captures oculomotor and speech dysfunction, early changes, and disease progression in ataxias.medRxiv : the preprint server for health sciences · 2025Article
- Comparing manual and automated methods for calculating speaking rate in Parkinson's disease.JASA express letters · 2025Article
- Article
- Multimodal Digital Phenotyping of Behavior in a Neurology Clinic: Development of the Neurobooth Platform and the First Two Years of Data Collection.medRxiv : the preprint server for health sciences · 2025Article
- Observational
- Access for ALL in ALS: A large-scale, inclusive, collaborative consortium to unlock the molecular and genetic mechanisms of amyotrophic lateral sclerosis.Muscle & nerve · 2024Review
- Multimodal speech biomarkers for remote monitoring of ALS disease progression.Computers in biology and medicine · 2024Article
- The relationship of rate and pause features to the communicative participation of people living with ALS.Muscle & nerve · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors at 10 institutions in 2 countries.
Carolina BarnettDivision of Neurology, Department of Medicine, University of Toronto and University Health Network, Toronto, Canada.
Jordan R GreenDepartment of Communication Sciences and Disorders, MGH Institute of Health Professions, Boston, MA, USA.ORCID 0000-0002-1464-1373
Reeman MarzouqahDepartment of Speech-Language Pathology, University of Toronto, Toronto, Canada.
Kaila L StipancicDepartment of Communication Sciences and Disorders, MGH Institute of Health Professions, Boston, MA, USA.
James D BerryHarvard Medical School, Department of Neurology, Massachusetts General Hospital (MGH), Boston, Massachusetts, USA,.
Lawrence KorngutDepartment of Clinical Neurosciences, Hotchkiss Brain Institute, University of Calgary, Calgary, Canada.
Angela GengeMontreal Neurological Institute, Neurosurgery, McGill University, Montreal, Canada.
Christen ShoesmithDepartment of Clinical Neurological Sciences, University of Western Ontario, London, Canada.
Hannah BriembergDivision of Neurology, University of British Columbia, Vancouver, Canada.
Agessandro AbrahaoDepartment of Medicine, Division of Neurology, Sunnybrook Health Sciences Centre, Toronto, Canada.ORCID 0000-0003-1142-2842
Sanjay KalraNeuroscience and Mental Health Institute, University of Alberta, Edmonton, Canada.
Lorne ZinmanDepartment of Medicine, Division of Neurology, Sunnybrook Health Sciences Centre, Toronto, Canada.
Yana YunusovaDepartment of Speech-Language Pathology, University of Toronto, Toronto, Canada.ORCID 0000-0002-2353-2275
Sunnybrook Health Science Centre · CAHarvard University · USMGH Institute of Health Professions · USMontreal Neurological Institute and Hospital · CAUniversity Health Network · CAUniversity of Alberta · CAUniversity of British Columbia · CAUniversity of Calgary · CAUniversity of Toronto · CAWestern University · CA
Funding
The development and validation of a novel tool for the assessment of bulbar dysfunction in ALSR01DC017291 · NIDCD · SUNNYBROOK RESEARCH INSTITUTE · PI JORDAN R GREEN, Yana Yunusova · 2018 to 2026
$3.6MSPEECH MOVEMENT CLASSIFICATION FOR ASSESSING AND TREATING ALSR01DC013547 · NIDCD · MGH INSTITUTE OF HEALTH PROFESSIONS · PI GREEN, JORDAN R · 2014 to 2018
$3.2MBulbar Motor Deterioration in ALSR01DC009890 · NIDCD · UNIVERSITY OF NEBRASKA LINCOLN · PI GREEN, JORDAN R, YUNUSOVA, YANA · 2009 to 2013
$2.3MCanadian Institutes for Health ResearchNIDCD NIH HHS R01 DC009890NIDCD NIH HHS R01 DC013547NIDCD NIH HHS R01 DC017291
Abstract
PubMed holds no abstract for this paper.
Indexed as
Early DiagnosisReadingAdultAgedAmyotrophic Lateral SclerosisDisease ProgressionFemaleHumansMaleMiddle AgedReproducibility of ResultsSpeechSpeech Production MeasurementBulbar ALSpassage readingpausesreliabilityspeaking ratevalidity
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
NCT05137665ClinicalTrials.gov
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.